hepatitis%20a%20-and-%20e
HEPATITIS A & E

Hepatitis A route of transmission is through oral-fecal route while in hepatitis E, aside from the oral-fecal route, it is also transmitted through blood transfusion in endemic areas.

Hepatitis A incubation period is 15-50 days and hepatitis E incubation period is 15-60 days.

Hepatitis A & E viruses cause epidemics.

 

Hepatitis%20a%20-and-%20e Treatment

General Care

Supportive Care

  • Consider hospitalization if there is vomiting, dehydration, signs of hepatic decompensation
  • Screen for other sexually-transmitted diseases (STDs) in cases of sexually acquired hepatitis or if otherwise appropriate

Hepatitis A

  • Supportive therapy is recommended; treatment for nausea and diarrhea should be given

Hepatitis E

  • Hepatitis E is a self-limiting disease and supportive therapy may be offered
  • Patients with severe acute hepatitis E or HEV-associated liver failure, or immunocompromised patients with chronic HEV may benefit from antiviral drugs (eg Ribavirin)
    • For immunocompromised patients with chronic HEV with persistent HEV detected by HEV RNA serum/stool testing after 12 weeks of Ribavirin treatment, additional 3 months monotherapy with Ribavirin may be considered
    • Pegylated interferon-α is a treatment option for liver transplant patients unresponsive to Ribavirin monotherapy
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, Yesterday

In obese patients without gallstones, a 6-month treatment course of ursodeoxycholic acid (UDCA) following bariatric surgery may reduce their likelihood of developing symptomatic gallstones, according to findings of the UPGRADE trial from The Netherlands presented at DDW 2021.